Mark E Burkard

24PUBLICATIONS
143CO-AUTHORS
Molecular targetsAutonomic nervous systemPhotonics, optoelectronics and optical communicationsCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Mar 26, 2026
Integrated Multiomic Profiling Identifies BRD8/EP400 as a Pivotal Chromatin Module Mediating Anti-HER2 Response in HR+/HER2+ Breast Cancer.

Ang Gao, Parth H Khatri, Gui Ma

|Dec 22, 2025
CRESTONE: A Phase II Study of the Efficacy and Safety of the HER3 Monoclonal Antibody, Seribantumab, in Solid Tumors With Neuregulin-1 (NRG1) Fusions.

Tejas Patil, Jessica J Lin, Parneet K Cheema

|Dec 03, 2024
One step 4× and 12× 3D-ExM enables robust super-resolution microscopy of nanoscale cellular structures.

Roshan X Norman, Yu-Chia Chen, Emma E Recchia

|Jun 04, 2024
CENP-E Inhibition Induces Chromosomal Instability and Synergizes with Diverse Microtubule-Targeting Agents in Breast Cancer.

John B Tucker, Caleb L Carlsen, Christina M Scribano

|May 29, 2024
Genetic Testing Utilization: Discrepancies Between Somatic and Germline Results in Patients With Cancer Reviewed at the UW Health Precision Medicine Molecular Tumor Board.

Isaac P Horn, Anna L Zakas, Kelcy J Smith-Simmer

|Apr 08, 2024
A survey of chromosomal instability measures across mechanistic models.

Andrew R Lynch, Shermineh Bradford, Amber S Zhou

Pageof 4

Frequent Collaborators

5 joint publications

Beth A Weaver

3 joint publications

Benjamin M Parsons

3 joint publications

John B Tucker

3 joint publications

Stephanie M McGregor